Medical Care Technologies Expands into Healthcare AI with New Melanoma Scan Preview
New York, Friday, 22 May 2026.
Expanding beyond its retail roots, Medical Care Technologies previewed an early-stage AI melanoma scanner today, marking a bold strategic pivot toward preventive healthcare and visual analysis technology.
A Broader Industry Shift Toward AI Diagnostics
Medical Care Technologies’ announcement arrives during a week of intense artificial intelligence integration across the broader healthcare sector [GPT]. Just days earlier, on Tuesday, May 19, 2026, global laboratory services giant Labcorp (NYSE: LH) launched MyLabcorp, an AI-powered mobile application designed to help consumers track health trends and interpret laboratory results [3]. Unlike MDCE’s early-stage beta, Labcorp’s application is already available on the Apple App Store and Google Play Store, leveraging OpenAI models to provide personalized health information within a secure, HIPAA-compliant platform [3].
The Expanding Footprint of Health Tech
The convergence of technology and medicine has dominated industry headlines throughout the third week of May 2026. On Thursday, May 21, 2026, Neuralink revealed a new robotic system designed for brain-computer interface (BCI) implant surgeries, while a mental health AI startup backed by Tony Robbins, The Path, successfully raised $14.3 million in funding [4]. Additionally, health tech firm Oura confidentially filed for an initial public offering following a period where its total revenue grew by more than four times over the past two fiscal years [4].